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Abstract Activation of cytoskeleton regulator Rho-
kinaseduringischemia–reperfusion(I/R)playsamajorrole
in I/R injury and apoptosis. Since Rho-kinase is a negative
regulator of the pro-survival phosphatidylinositol 3-kinase
(PI3-kinase)/Akt pathway, we hypothesized that inhibition
of Rho-kinase can prevent I/R-induced endothelial cell
apoptosis by maintaining PI3-kinase/Akt activity and that
protectiveeffectsofRho-kinaseinhibitionarefacilitatedby
prevention of F-actin rearrangement. Human umbilical
vein endothelial cells were subjected to 1 h of simulated
ischemia and 1 or 24 h of simulated reperfusion after
treatment with Rho-kinase inhibitor Y-27632, PI3-kinase
inhibitor wortmannin, F-actin depolymerizers cytochalasinD
and latrunculinA and F-actin stabilizer jasplakinolide. Intra-
cellular ATP levels decreased following I/R. Y-27632
treatment reduced I/R-induced apoptosis by 31% (P\0.01)
and maintained Akt activity. Both effects were blocked by
co-treatment with wortmannin. Y-27632 treatment pre-
vented the formation of F-actin bundles during I/R. Similar
results were observed with cytochalasinD treatment. In
contrast, latrunculinA and jasplakinolide treatment did not
prevent the formation of F-actin bundles during I/R and had
no effect on I/R-induced apoptosis. Apoptosis and Akt
activity were inversely correlated (R
2 = 0.68, P\0.05).
In conclusion, prevention of F-actin rearrangement by
Rho-kinase inhibition or by cytochalasinD treatment atten-
uated I/R-induced endothelial cell apoptosis by maintaining
PI3-kinase and Akt activity.
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Introduction
Experimental ischemia and reperfusion (I/R) induces
endothelial cell apoptosis in several organs [1, 2]. We and
others have previously shown that activation of RhoA and
downstream effector Rho-kinase during experimental I/R
plays a major role in I/R injury and associated apoptosis
[3–7]. Indeed, Rho-kinase inhibition has beneﬁcial effects
on I/R injury in several organs [4, 6–12]. Endothelial cells
may be essential for mediating the beneﬁcial effects of
Rho-kinase inhibition on I/R injury, because, for instance
inhibition of endothelial nitric oxide synthase blocked the
beneﬁcial effects of Rho-kinase inhibition on rat myocar-
dial infarct size [12].
Rho-kinase activation during the execution of apoptosis
results in increased myosin activity, bundling of F-actin by
activated myosins, actin–myosin contractile force genera-
tion, cell contraction and ultimately membrane blebbing
[13–15]. Recent in vivo and in vitro studies suggest that
Rho-kinase and the effects of Rho-kinase on the actin–
myosin cytoskeleton may also be involved in the initiation
of apoptosis [4, 12, 16–20]. Rho-kinase is a negative reg-
ulator of the pro-survival phosphatidylinositol 3-kinase
(PI3-kinase)/Akt pathway and it upregulates mitochondrial
death pathway protein Bax [4, 12, 16, 19]. The effects of
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in linking Rho-kinase activation and PI3-kinase/Akt
inactivation.
We hypothesized that (1) inhibition of Rho-kinase can
prevent I/R-induced endothelial cell apoptosis by main-
taining PI3-kinase and Akt activity and (2) prevention of
F-actin rearrangement facilitates the protective effects of
Rho-kinase inhibition (Fig. 1). To test this hypothesis, we
assessed whether speciﬁc inhibition of Rho-kinase with
Y-27632 [21] attenuates apoptosis via phosphorylation of
Akt in an in vitro model of simulated I/R. The involvement
of the F-actin cytoskeleton was explored by the use of
F-actin depolymerizers cytochalasinD and latrunculinA
and F-actin stabilizer jasplakinolide [22].
Materials and methods
Cell culture
Human Umbilical Vein Endothelial Cells (HUVECs) were
isolated, cultured and characterized as previously described
[23]. Brieﬂy, HUVECs were cultured on gelatin-coated
wells/glass cover slips until conﬂuent at 37C under 5%
CO2/95% air atmosphere. Culture medium was renewed
every other day (medium 199 supplemented with 10%
heat-inactivated human serum, 10% heat-inactivated new
born calf serum, 150 lg/ml crude endothelial cell growth
factor, 2 mM L-glutamine, 5 U/ml heparin, 100 IU/ml
penicillin, and 100 lg/ml streptomycin).
Simulation of I/R
We used an established in vitro endothelial cell model for
simulation of ischemia and reperfusion [24, 25]. Figure 2
shows a schematic representation of the experimental
protocol. Cells were washed twice with washing buffer
(1.2 mM MgSO4   7H2O, 116 mM NaCl, 5.3 mM KCl,
1.13 mM NaH2PO4   H2O, 1.8 mM CaCl2   2H2O, 20 mM
HEPES) and treated for 1 h with washing buffer with or
without 10 lM Y-27632 (Tocris Cookson Ltd., Bristol,
United Kingdom (UK)), 250 nM cytochalasinD (Sigma-
Aldrich, Saint Louis, Missouri, United States of America
(USA)), 150 nM latrunculinA (Calbiochem, Darmstadt,
Germany), 20 nM jasplakinolide (Calbiochem) and 50 nM
wortmannin (Sigma-Aldrich). This was followed by 1 h of
simulated ischemia by covering cells with 1 ml mineral oil
(nitrogen bubbled) and subsequently simulated reperfusion
by replacement of culture medium for different time points:
no reperfusion for adenosine tri-phosphate (ATP) mea-
surement and F-actin staining, 1 h for ATP measurement,
F-actin staining and western blotting to analyze phospho
Akt (pAkt) levels and 24 h for quantiﬁcation of apoptosis.
Drugs were also present during simulated reperfusion. As
controls, we used cells treated for 1 h with washing buffer
followed by treatment with medium (control) or medium
supplemented with 10% mineral oil (control oil) to assess
any injurious effects of products within the oil.
ATP measurement
We measured ATP after ischemia and I/R (1 h of reper-
fusion) in order to conﬁrm ischemic substrate deprivation.
Cells were grown in a gelatin-coated 12-well chamber
and treated according to the simulated I/R protocol. ATP
was measured using the ENLITEN ATP Assay System
Bioluminiscence Detection Kit for ATP (Promega Corpo-
ration, Madison, Wisconsin, USA). Proteins in lysate were
Fig. 1 Proposed mechanism for modulation of I/R-induced apoptosis
involving RhoA/Rho-kinase and PI3-kinase/Akt. Simulated I/R
activates RhoA/Rho-kinase [3–7], which leads to F-actin rearrange-
ment. F-actin rearrangement facilitates reduction of PI3-kinase/Akt
activity and induction of apoptosis. This can be prevented by
inhibition of Rho-kinase with Y-27632. The protective effects of
Y-27632 can be blocked with PI3-kinase inhibitor wortmannin.
Several other pathways for I/R-induced apoptosis are represented by
the dashed arrow [2, 19]
Fig. 2 Schematic representation of the experimental protocol. Cells
were pre-treated for 1 h with Y-27632, cytochalasinD, latrunculinA,
jasplakinolide or wortmannin. One hour of simulated ischemia was
followed by 1–24 h of simulated reperfusion. No reperfusion for ATP
measurement and F-actin staining, 1 h for ATP measurement, F-actin
staining and analysis of Akt activity by western blotting and 24 h for
quantiﬁcation of apoptosis. The drugs were also present during the
reperfusion phase
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123measured with BCA Protein Assay Kit (Pierce, Rockford,
Illinois, USA) in order to calculate nmol ATP/lg protein.
Quantiﬁcation of apoptosis
The cells were grown in a 24-well chamber on gelatin-
coated glass cover slips and treated according to the sim-
ulated I/R protocol (24 h of reperfusion). Cells were ﬁxed
in 4% formaldehyde and permeabilized with 0.2% triton
X-100 (Sigma-Aldrich). The nucleus was stained with
40,6-diamidino-2-phenylindole (DAPI) in Vectashield

Mounting medium (Vector Laboratories, Inc., Burlingame,
California, USA). Apoptosis on each glass cover slip was
quantiﬁed using a DeadEnd
TM Fluorometric TdT-mediated
dUTP Nick End Labeling (TUNEL) System (Promega
Corporation) with ﬂuorescence microscopy using a Mari-
anas
TM digital imaging microscope and Slidebook 4.2
software (Intelligent Imaging Innovations, Inc., Denver,
Colorado, USA). The number of apoptotic nuclei (TUNEL-
positive) and the total number of nuclei (DAPI-positive)
were counted in three non-overlapping microscope ﬁelds/
glass cover slip using a 109 air lens (Carl Zeiss B.V.,
Sliedrecht, The Netherlands) and averaged. The number of
apoptotic nuclei was expressed as percentage of the total
number of nuclei.
F-actin cytoskeleton staining
The cells were grown in a 24-well chamber on gelatin-
coated glass cover slips and treated according to the
simulated I/R protocol (1 h of reperfusion). Cells were
ﬁxed in 4% formaldehyde and permeabilized with 0.2%
triton X-100. F-actin was stained with rhodamin-phalloidin
(1:100) (Molecular Probes, Inc., Eugene, Oregon, USA)
and the nucleus with DAPI in Vectashield
 Mounting
medium. Cells were visualized with ﬂuorescence micros-
copy and Slidebook software.
Analysis of Akt phosphorylation
Cellsweregrowninagelatincoated6-wellchamber,treated
according to the simulated I/R protocol (1 h of reperfusion)
and lysated with lysis buffer (20 mM Tris/HCl pH 8.0,
150 mM NaCl, 90 mM KCl, 2 mM EDTA/NaOH pH 8.0,
igepal(1:200),tritonX-100(1:200),1 mMNa3VO4,10mM
NaF, protease inhibitors (1:100), phosphatase inhibitors
(1:100)). Protein concentration was measured (BCA
method) and equal amounts of protein from each sample
were separated by SDS-PAGE and electrophoretically
transferred to a nitrocellulose membrane (Bio-Rad
Laboratories, Hercules, California, USA). Membranes were
incubated with polyclonal antibodies against pAkt (serine-
473, rabbit, 1:1,000) and total Akt (tAkt, rabbit, 1:1,000)
(Cell Signaling Technology, Inc., Danvers, Massachusetts,
USA). tAkt was used as loading control. Goat anti-rabbit
immunoglobulins horseradish peroxidase (HRP) from Dako
Cytomation (Glostrup, Denmark) was used for the detection
of the primary antibodies at 1:1,000. Detection of the HRP
reaction was performed with ECL plus Western Blotting
Detection System (Amersham Biosciences, Little Chalfont
Buckinghamshire, UK). Imaging and analysis were per-
formed with LAS-3000 (Fuji Photo Film Co., Ltd., Tokyo,
Japan) and AIDA Image Analyzer (Raytest GmbH,
Straubenhardt,Germany).DatawereexpressedaspAkt/tAkt
as percentage of control.
Statistical analysis
A one-way analysis of variance (ANOVA) was conducted
to explore the effects of I/R, Y-27632, cytochalasinD or
wortmannin treatment, and their interaction on apoptosis.
The t-test was used to further analyse the differences
between the groups when ANOVA indicated statistical
signiﬁcance. We adjusted for multiple testing with help of
the Bonferroni Holm method. The paired t-test was used
for paired ATP data and logarithmic transformed absolute
pAkt/tAkt data. Absolute pAkt/tAkt data were logarithmic
transformed to obtain a Gaussian distribution. We adjusted
for multiple testing with help of the Bonferroni Holm
method. The Pearson coefﬁcient of determination (R
2) was
used to express the relation between the percentage of
apoptotic nuclei and the logarithmic transformed absolute
pAkt/tAkt data. Differences were considered signiﬁcant at
the P\0.05 level. Data are presented as means ± stan-
dard error of the mean (SEM).
Results
ATP levels and apoptosis following simulated ischemia
and I/R
In order to conﬁrm ischemic substrate deprivation in simu-
lated I/R, we measured intracellular ATP levels. Ischemia
was simulated by covering the monolayer of cells with
nitrogen bubbled mineral oil. Reperfusion was simulated by
replacement of culture medium (Fig. 2). Intracellular ATP
levels decreased following simulated ischemia compared to
the levels in cells treated with medium supplemented with
10% mineral oil (control oil) (0.15 ± 0.04 nmol ATP/lg
proteinversus0.22 ± 0.04 nmolATP/lgprotein,P\0.05,
n = 7). Intracellular ATP decreased even further during the
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123reperfusion phase (0.10 ± 0.04 nmol ATP/lg protein,
P\0.05versuscontroloil,n = 7).ATPlevelsofcontroloil
cells were comparable to those of control cells
(0.20 ± 0.04 nmol ATP/lg protein, n = 7). Simulated I/R
induced a signiﬁcant percentage of apoptotic nuclei
(ANOVA for the effect of I/R on apoptosis, P\0.0001),
while hardly any apoptosis was observed in control and
control oil cells (Fig. 3).
The effect of Rho-kinase inhibition on apoptosis
To investigate the role of Rho-kinase during I/R-induced
apoptosis, HUVECs were treated with inhibitor Y-27632
duringsimulatedI/R(Fig. 3).Y-27632hadnoeffectonbasal
apoptosis, but reduced the degree of apoptosis during I/R
(ANOVA for the effects of Y-27632 and the interaction
between I/R and Y-27632 on apoptosis, both P\0.01). To
determine whether the protective effects of Rho-kinase inhi-
bitionweremediatedbyPI3-kinase,cellswereco-treatedwith
PI3-kinase inhibitor wortmannin. Wortmannin had no effect
on basal apoptosis, but blocked the protective effect of Rho-
kinase inhibition during I/R (ANOVA for the effect of wort-
mannin on apoptosis, P\0.05).
Akt activity in Y-27632-mediated protection
against apoptosis
To investigate the effect of Y-27632 treatment during I/R
on Akt activity, Akt phosphorylation was analyzed by
western blotting (Fig. 4). Simulated I/R reduced Akt
activity compared to non-treated or Y-27632-treated
control cells. Y-27632 treatment maintained Akt activity in
I/R cells. To determine whether this effect was mediated by
PI3-kinase, cells were co-treated with wortmannin. Wort-
mannin blocked the Y-27632-induced maintenance of Akt
activity. Akt activity in Y-27632- (Fig. 4) or wortmannin-
treated control cells (preliminary data) was comparable to
the activity in non-treated control cells.
The F-actin cytoskeleton in Y-27632-mediated
protection against apoptosis
To investigate whether Y-27632-mediated protection
against apoptosis paralleled the absence of Rho-kinase-
mediated F-actin rearrangement, the F-actin cytoskeleton
was visualized with rhodamin-phalloidin in non-treated or
Y-27632-treated control, simulated ischemia and simulated
I/R cells (n = 9, representative pictures are shown in
Fig. 5). Y-27632-treated control cells showed a slight
decrease in peripheral F-actin bundles compared non-
treated control cells, indicating that in vitro inhibition of
Rho-kinase was able to reduce F-actin bundle formation.
After simulated ischemia in non-treated cells, some F-actin
bundles appeared in the cytoplasm. Y-27632-treated
ischemic cells showed only F-actin clumps. After simulated
Fig. 3 Rho-kinase inhibition reduces the degree of apoptosis during
I/R via PI3-kinase. Non-treated control (C, n = 11), control oil (C O,
n = 2), Y-27632-treated control (C Y, n = 11) and wortmannin-
treated control (C W, n = 5) showed hardly any apoptosis. Simulated
I/R induced a signiﬁcant percentage of apoptotic nuclei (minimum
P\0.005 versus the controls, n = 12). Y-27632 treatment reduced
the percentage of apoptotic nuclei during simulated I/R (I/R Y,
*P\0.01, n = 12). This protective effect was completely blocked
by wortmannin (I/R YW,
#P\0.05, n = 5). The number of apoptotic
nuclei is expressed as percentage of total number of nuclei. Data are
presented as means ± SEM
Fig. 4 Rho-kinase inhibition maintains Akt activity during I/R.
A representative western blot of pAkt and tAkt is shown in the upper
panel and a graph of pAkt/tAkt as percentage of control in the lower
panel. Simulated I/R (I/R, n = 15) induced a decrease in pAkt
compared to the control and the Y-27632-treated control (C Y,
*P\0.05, n = 15). Y-27632 treatment during simulated I/R main-
tained pAkt levels (I/R Y, **P\0.05, n = 14). Wortmannin blocked
the Y-27632-induced maintenance of Akt activity (I/R YW,
#P\0.05, n = 12). Data are presented as means ± SEM. Absolute
pAkt/tAkt data in arbitrary units (a.u.): control: 0.75 a.u.; C Y:
0.64 a.u.; I/R: 0.32 a.u.; I/R Y: 0.36 a.u.; I/R YW: 0.04 a.u
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123reperfusion, even more F-actin bundles appeared in the
periphery and the cytoplasm of the non-treated cells. In
contrast, Y-27632-treated I/R cells, showed no F-actin
bundles.
To further investigate the role of the F-actin cytoskeleton
in I/R-induced apoptosis, we used F-actin depolymerizers
cytochalasinD and latrunculinA and F-actin stabilizer
jasplakinolide (Fig. 5). CytochalasinD-treated control cells
Fig. 5 Y-27632 and
cytochalasinD prevent F-actin
bundle formation during I/R.
Shown is ﬂuorescent imaging of
rhodamin-phalloidin stained
F-actin structures and DAPI
stained nuclei in non-treated,
Y-27632-, cytochalasinD-,
latrunculinA- and
jasplakinolide-treated control,
simulated ischemia and
simulated I/R cells. The arrow
and * indicate F-actin bundles
and F-actin clumps,
respectively. Control cells:I n
non-treated cells, most F-actin
bundles were seen in the
periphery of the cell. Y-27632-
treated cells showed a slight
decrease in peripheral F-actin
bundles. CytochalasinD-treated
cells showed only F-actin
clumps. Cells treated with
latrunculinA or jasplakinolide
showed a slight decrease and
increase in F-actin bundles,
respectively. Ischemic cells:
Non-treated cells showed
F-actin bundles throughout the
whole cell. Cells treated with
Y-27632, cytochalasinD or
latrunculinA showed only
F-actin clumps. Jasplakinolide-
treated cells showed F-actin
bundles. I/R cells: Non-treated
cells showed F-actin bundles
throughout the whole cell. In
Y-27632-treated cells, no
F-actin bundles were seen.
CytochalasinD-treated cells
showed also no F-actin bundles,
only F-actin clumps were
visible. LatrunculinA-treated
cells showed some F-actin
bundles. Jasplakinolide-treated
cells showed as many F-actin
bundles as non-treated I/R cells
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123showed no F-actin bundles. LatrunculinA-treated control
cells showed a slight decrease and jasplakinolide-treated
control cells showed a slight increase in F-actin bundles
compared to non-treated control cells. CytochalasinD- and
latrunculinA-treated ischemic cells showed no F-actin bun-
dles, only F-actin clumps were visible. Jasplakinolide-
treatedischemiccellsshowedF-actinbundlesthroughoutthe
whole cell. In cytochalasinD-treated I/R cells, no F-actin
bundles were visible, only F-actin clumps could be seen.
In contrast, latrunculinA-treated I/R cells still showed some
F-actin bundles and jasplakinolide-treated I/R cells showed
as many F-actin bundles as non-treated I/R cells.
Since cytochalasinD treatment prevented F-actin rear-
rangement similarly to Y-27632 treatment, we investigated
whether cytochalasinD treatment could also prevent
apoptosis during simulated I/R (Fig. 6). CytochalasinD had
no effect on basal apoptosis, but reduced the degree of
apoptosis during I/R (ANOVA for the effects of cytocha-
lasinD and the interaction between I/R and cytochalasinD
on apoptosis, both P\0.05). Wortmannin blocked the
protective effect of cytochalasinD in I/R (ANOVA for the
effect of wortmannin on apoptosis, P\0.0001). In con-
trast to the protective effect of Y-27632 and cytochalasinD
on apoptosis, latrunculinA and jasplakinolide did not affect
I/R-induced apoptosis, also not in co-treatment with
wortmannin (data not shown). LatrunculinA and jasplaki-
nolide had no effect on basal apoptosis (data not shown).
Furthermore, cytochalasinD maintained Akt activity
during simulated I/R (Fig. 7). Co-treatment with wort-
mannin completely blocked the cytochalasinD-induced
maintenance of Akt activity. Akt activity in cytochalasinD-
treated control cells was comparable to the activity in non-
treated control cells.
Interestingly, the percentage of apoptotic nuclei inver-
sely correlated to Akt activity (Fig. 8), indicating that a
decrease in Akt activity correlated to an increase in
apoptosis.
Discussion
Thisstudyshowsthat(1)inhibitionofRho-kinaseattenuates
I/R-induced endothelial cell apoptosis by maintaining PI3-
kinase and Akt activity and (2) the effects of Rho-kinase
Fig. 6 CytochalasinD reduces the degree of apoptosis during I/R via
PI3-kinase. Non-treated control (C, n = 6) and cytochalasinD-treated
control (C CytoD, n = 6) showed hardly any apoptosis. Simulated I/R
induced a signiﬁcant percentage of apoptotic nuclei (P\0.0001
versus the controls, n = 6). Treatment with cytochalasinD reduced
the percentage of apoptotic nuclei in simulated I/R (I/R CytoD,
*P\0.05, n = 6). This protective effect was completely blocked by
wortmannin (I/R CytoDW,
#P\0.005, n = 6). The number of
apoptotic nuclei is expressed as percentage of total number of nuclei.
Data are presented as means ± SEM
Fig. 7 CytochalasinD treatment maintains Akt activity during I/R.
Simulated I/R (I/R, n = 11) induced a decrease in pAkt compared to
the control and the cytochalasinD-treated control (C CytoD,
*P\0.01, n = 11). CytochalasinD treatment during simulated I/R
maintained pAkt levels (I/R CytoD, **P\0.05, n = 11). Wortman-
nin blocked the cytochalasinD-induced maintenance of Akt activity
(I/R CytoDW,
#P\0.01, n = 7). Data are presented as means ±
SEM. Absolute pAkt/tAkt data in arbitrary units (a.u.): control:
0.61 a.u.; C CytoD: 0.84 a.u.; I/R: 0.36 a.u.; I/R CytoD: 0.54 a.u.; I/R
CytoDW: 0.05 a.u
Fig. 8 The percentage of apoptotic nuclei inversely correlates to Akt
activity (R
2 = 0.68, P\0.05). Mean percentage of apoptotic nuclei
and mean logarithmic transformed absolute pAkt/tAkt levels in non-
treated (C), Y-27632 (C Y)- and cytochalasinD (C CytoD)-treated
control cells and in non-treated (I/R), Y-27632 (I/R Y)-, cytochalasinD
(I/R CytoD)- and wortmannin (I/R YW and I/R CytoDW)- treated I/R
cells are shown as *
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123inhibition on PI3-kinase/Akt and apoptosis are facilitated by
prevention of F-actin rearrangement.
Our data point to a novel mechanistic link between
activation of Rho-kinase during I/R and negative regulation
of PI3-kinase/Akt, namely the effect of Rho-kinase on
F-actin rearrangement (Fig. 1). Prevention of F-actin
rearrangement by Rho-kinase inhibition or by treatment
with actin depolymerizer cytochalasinD, independent of
Rho-kinase, both attenuated I/R-induced endothelial cell
apoptosis by maintaining PI3-kinase and Akt activity.
Indeed, it has been reported previously that cytochalasins
inhibited in vivo and in vitro apoptosis induced by a
variety of stimuli, including I/R [5, 13, 26]. This study is
therefore an extension of and a link between reports on
Rho-kinase as negative regulator of the PI3-kinase/Akt
pathway and reports on the involvement of Rho-kinase-
dependent cytoskeletal rearrangement in the initiation of
apoptosis [4, 12, 16–20].
Actin depolymerizer latrunculinA did not affect
I/R-induced endothelial cell apoptosis. This may be
explained by the natureand degree of F-actinrearrangement
during I/R, since F-actin bundles were completely absent
in Y-27632- and cytochalasinD-treated I/R cells, while
latrunculinA-treated cells still showed some bundles.
Indeed, cytochalasinD and latrunculinA depolymerize
F-actin by different mechanisms and induce different pat-
terns in vitro [22, 27]. CytochalasinD caps the barbed end of
actin ﬁlaments, severs actin ﬁlaments, sequesters actin
monomers or dimers, promotes nucleation and stimulates the
ATPase activity of G-actin. In vitro in hamster ﬁbroblasts, it
caused a complete collapse of the stress ﬁbers at concentra-
tions comparable to ours [22, 27]. LatrunculinA on the
other hand binds to monomeric G-actin to form a non-
polymerizable complex and caused concentration-dependent
shortening and thickening of stress ﬁbers in the ﬁbroblasts at
concentrations comparable to ours [22, 27]. Jasplakinolide,
which promotes actin polymerization and stabilizes actin
ﬁlaments by binding to F-actin [22], induced as many F-actin
bundles in I/R as non-treated I/R cells and consequently did
not affect I/R-induced endothelial apoptosis. However, in
vivo it has been demonstrated that jasplakinolide prevented
I/R-induced apoptosis in the rat kidney, while latrunculinB
increased I/R-induced apoptosis in rat kidney [28, 29]. Fur-
thermore,weobservedhardlyanyapoptosis inourY-27632-,
cytochalasinD-, latrunculinA- and jasplakinolide-treated
control cells, while some reports describe the induction
of apoptosis in control cells by latrunculinAor jasplakinolide
at much higher concentrations than ours [30, 31], by
cytochalasinD in airway epithelial cells, but not in canine
kidney epithelial cells [32] or by Y-27632 in airway
epithelial cells [32]. Therefore, these discrepancies may be
explained by the use of different concentrations, cell types or
the use of an in vivo/in vitro model.
Akt activation after 1 h of reperfusion inversely corre-
lated to the percentage of apoptosis after 24 h of
reperfusion. Therefore, early reduced Akt activity
may have a predictive value for the development of late
I/R-induced apoptosis. The preventive effect of Y-27632
and cytochalasinD treatment probably takes place early in
the process of apoptosis, because the Y-27632-induced
increase in Akt activity is rapid and transient with a max-
imum after 30 min [12, 16]. Indeed, we could neither
detect increased Akt activity in our Y-27632-treated con-
trol cells after 3 h nor in our Y-27632-treated I/R cells after
24 h of reperfusion (pilot study, data not shown), possibly
because this was to late to detect the peak in Akt activity.
I/R-induced apoptosis was maximal as late as after 24–48 h
of reperfusion [25]. Therefore, apoptosis was quantiﬁed
after 24 h of reperfusion. Indeed, we did not see any
TUNEL-positive nuclei after 1 h of reperfusion (pilot
study, data not shown). Our percentage of apoptotic nuclei
was comparable to the percentage reported by the devel-
opers of the simulated I/R model [25]. However, less
endothelial cell apoptosis was observed in a model of
hypoxia/reoxygenation [33], possibly because this induces
less severe metabolic deprivation. In addition, PI3-kinase
inhibition did not decrease basal Akt activity nor increased
basal apoptosis, while it blocked the effects of Rho-kinase
inhibition on I/R-induced apoptosis and Akt activity. This
suggests that the basal situation is independent of
PI3-kinase, while the effects Rho-kinase inhibition during
I/R are dependent on PI3-kinase.
Although it is unclear by which mechanism F-actin
rearrangement facilitates the effects of Rho-kinase on
PI3-kinase/Akt and apoptosis, several mechanisms can be
proposed. First, RhoA and Rho-kinase may regulate pAkt
levels by regulating phosphatase and tensin homologue
(PTEN) activity. PTEN is in inactive state in the cytosol
and translocates to the membrane upon RhoA or Rho-
kinase-induced activation, where it can inhibit the phos-
phorylation of Akt via PI3-kinase [34]. Disruption of the
F-actin bundles by Rho-kinase inhibition or cytochalasinD
treatment or the direct effects of Rho-kinase inhibition on
PTEN may prevent the translocation and activation of
PTEN, thereby preventing its inhibitory effect on Akt
phosphorylation. Furthermore, there may be some PI3-
kinase independent mechanisms involved in the Y-27632-
induced protection against apoptosis. It is reported that
F-actin polymerization and actin–myosin contractility are
necessary for membrane blebbing and chromatin conden-
sation during execution of apoptosis induced by tumor
necrosis factor-a or overexpression of Rho-kinase [13, 26].
Moreover, the actin–myosin cytoskeleton may be involved
in facilitating the cellular localization of speciﬁc compo-
nentsoftheapoptoticmachineryandberequiredforcaspase-
3 activation [17, 18].
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123Our study carries some limitations. First, we cannot
conclude on the mechanisms by which F-actin rearrange-
ment facilitates the effects of Rho-kinase on PI3-kinase/
Akt and apoptosis. Second, Rho-kinase inhibition and
F-actin depolymerization could establish only a partial
protection against apoptosis, in agreement with the litera-
ture [4, 5, 8, 12], possibly because other mechanisms are
also involved and the I/R-induced injury is too extensive.
Third, we may have underestimated the number of apop-
totic cells, because endothelial cells that detached from the
basement membrane during simulated I/R and did not
reattach later were not counted in the quantiﬁcation of
apoptosis. Indeed, Prahalad et al. [35] describe this
reversible cell detachment during ATP depletion of Madin-
Darby canine kidney cells.
Conclusion
Prevention of F-actin rearrangement or F-actin bundle
formation by Rho-kinase inhibition or by treatment with
actin depolymerizator cytochalasinD, independent of Rho-
kinase, attenuated I/R-induced endothelial cell apoptosis by
maintaining PI3-kinase and Akt activity. The present
ﬁnding suggests that the changes in the F-actin cytoskele-
ton play a pivotal role in the negative regulation of
PI3-kinase and Akt by Rho-kinase. Further studies are
required to conclude on the mechanisms by which F-actin
rearrangement facilitates the effects of Rho-kinase on
PI3-kinase/Akt and apoptosis.
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